Weide B - Search Results

1

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

Mangana J, Cheng PF, Schindler K, Weide B, Held U, Frauchiger AL, Romano E, Kähler KC, Rozati S, Rechsteiner M, Moch H, Michielin O, Garbe C, Hauschild A, Hoeller C, Dummer R, Goldinger SM. Mangana J, et al. Among authors: weide b. PLoS One. 2015 Oct 1;10(10):e0139438. doi: 10.1371/journal.pone.0139438. eCollection 2015. PLoS One. 2015. PMID: 26426340 Free PMC article.

2

Is morphoea caused by Borrelia burgdorferi? A review.

Weide B, Walz T, Garbe C. Weide B, et al. Br J Dermatol. 2000 Apr;142(4):636-44. doi: 10.1046/j.1365-2133.2000.03407.x. Br J Dermatol. 2000. PMID: 10792212 Review.

3

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.

Radny P, Caroli UM, Bauer J, Paul T, Schlegel C, Eigentler TK, Weide B, Schwarz M, Garbe C. Radny P, et al. Among authors: weide b. Br J Cancer. 2003 Nov 3;89(9):1620-6. doi: 10.1038/sj.bjc.6601320. Br J Cancer. 2003. PMID: 14583759 Free PMC article. Clinical Trial.

4

Imiquimod in the treatment of extensive recurrent lentigo maligna.

Kamin A, Eigentler TK, Radny P, Bauer J, Weide B, Garbe C. Kamin A, et al. Among authors: weide b. J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):51-2. doi: 10.1016/j.jaad.2004.07.047. J Am Acad Dermatol. 2005. PMID: 15692515

5

[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].

Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C. Eigentler TK, et al. Among authors: weide b. J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. doi: 10.1111/j.1610-0387.2005.05051.x. J Dtsch Dermatol Ges. 2005. PMID: 16033477 Review. German.

6

Plasmid DNA- and messenger RNA-based anti-cancer vaccination.

Weide B, Garbe C, Rammensee HG, Pascolo S. Weide B, et al. Immunol Lett. 2008 Jan 15;115(1):33-42. doi: 10.1016/j.imlet.2007.09.012. Epub 2007 Oct 26. Immunol Lett. 2008. PMID: 18006079 Review.

7

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

Weide B, Carralot JP, Reese A, Scheel B, Eigentler TK, Hoerr I, Rammensee HG, Garbe C, Pascolo S. Weide B, et al. J Immunother. 2008 Feb-Mar;31(2):180-8. doi: 10.1097/CJI.0b013e31815ce501. J Immunother. 2008. PMID: 18481387 Clinical Trial.

8

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

Weide B, Pascolo S, Scheel B, Derhovanessian E, Pflugfelder A, Eigentler TK, Pawelec G, Hoerr I, Rammensee HG, Garbe C. Weide B, et al. J Immunother. 2009 Jun;32(5):498-507. doi: 10.1097/CJI.0b013e3181a00068. J Immunother. 2009. PMID: 19609242 Clinical Trial.

9

Melanoma staging: facts and controversies.

Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C. Forschner A, et al. Among authors: weide b. Clin Dermatol. 2010 May-Jun;28(3):275-80. doi: 10.1016/j.clindermatol.2009.06.012. Clin Dermatol. 2010. PMID: 20541679

10

Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.

Leiter U, Eigentler TK, Forschner A, Pflugfelder A, Weide B, Held L, Meier F, Garbe C. Leiter U, et al. Among authors: weide b. Clin Dermatol. 2010 May-Jun;28(3):311-5. doi: 10.1016/j.clindermatol.2009.10.001. Clin Dermatol. 2010. PMID: 20541684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters